• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > General > February 17, 2011

      FDA Approves New Test to Monitor Level of Drug in Kidney Transplant Patients

      Posted Atmedindia.net

      The US Food and Drug Administration has revealed that it has approved a new test which will monitor the level of a drug which is used in kidney transplant patients to prevent the rejection of the transplanted organ by the body.

      The FDA had last year approved an everolimus drug, Zortress, which is manufactured by Novartis. The drug was effective in suppressing the immune system of a kidney transplant patient and prevent the rejected on the transplanted kidney.

      However recent studies revealed that high levels of such drugs, also known as immunosuppressant, can be toxic to the body. Thermo Fisher Scientific Inc came up with a new test that will monitor the levels of such immunosuppressant in the blood levels.

      Known as QMS Everolimus Immunoassay, the test will help the doctors to monitor the level of Zortress in the blood stream. With the patients having to take the drug throughout their lives, the test is expected to provide an advance notice of building of immunosuppressant in the blood stream to the doctors and help them take preventive measures.

      Feb 17, 2011


      Share this Article!

    Back to top^